P53 mutations occur in about 80% of tissue samples from lung cancer patients (Cancer Genome Atlas Research Network, 2012), suggesting that the role of OTUD5 as a tumor suppressor may not solely depend on the regulation of p53. Here, TP53 is linked to neoplasm.